New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 2, 2014
09:20 EDTCVX, NTRI, BCOR, SREV, SQI, BIRT, RXII, INVN, IMMU, OPEN, AVNR, ISRG, SQNM, MRK, ECYT, RBS, AXLOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Royal Bank of Scotland (RBS), up 9%... Sequenom (SQNM), up 8.2%... Nutrisystem (NTRI), up 11.5%... American Axle (AXL), up 2.9%. ALSO HIGHER: Wynn Resorts (WYNN), up 4% after earnings, shares upgraded at Sterne Agee... Avanir (AVNR), up 3.7% after upgraded at Mizuho... RXi Pharmaceuticals (RXII), up 27.4% after announcing results from study of RXI-109... Intuitive Surgical (ISRG), up 4% after announcing accelerated share repurchase. DOWN AFTER EARNINGS: Chevron (CVX), down 1%... OpenTable (OPEN), down 3.4%... Actuate (BIRT), down 18.2%... SciQuest (SQI), down 20%... ServiceSource (SREV), down 15.2%. ALSO LOWER: Endocyte (ECYT), down 60% after announcing DSMB recommends vintafolide PROCEED trial be stopped. The drug is being developed in partnership with Merck (MRK)... Immunomedics (IMMU), down 16% after filing to sell $30M worth of common stock in a spot secondary offering... InvenSense (INVN), down 9.3% after downgraded at Needham following the company's Q4 earnings report... Blucora (BCOR), down 10% after earnings, downgrade at Craig-Hallum.
News For CVX;RBS;ECYT;MRK;SQNM;ISRG;AVNR;OPEN;IMMU;INVN;RXII;BIRT;SQI;SREV;BCOR;NTRI;AXL From The Last 14 Days
Check below for free stories on CVX;RBS;ECYT;MRK;SQNM;ISRG;AVNR;OPEN;IMMU;INVN;RXII;BIRT;SQI;SREV;BCOR;NTRI;AXL the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 14, 2014
10:05 EDTAXLOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:07 EDTRXIIRXi Pharmaceuticals reports Q2 EPS (23c), consensus (25c)
Subscribe for More Information
August 13, 2014
18:02 EDTMRKMerck provides statement on role of PNEUMOVAX 23 in updated ACIP recommendations
Subscribe for More Information
16:52 EDTMRKMerck confirms FDA approval of BELSOMRA
Subscribe for More Information
16:17 EDTAXLAmerican Axle initiated with a Neutral at Credit Suisse
Subscribe for More Information
15:30 EDTMRKFDA approves Belsomra sleep drug
The Food and Drug Administration approved Belsomra tablets for use as needed to treat difficulty in falling and staying asleep. Belsomra is an orexin receptor antagonist and is the first approved drug of this type. Belsomra will be dispensed with an FDA-approved patient Medication Guide that provides instructions for its use and important safety information. Belsomra is a controlled substance because it can be abused or lead to dependence. Belsomra is made by Merck, Sharpe & Dohme.
August 12, 2014
15:53 EDTSQICanaccord to hold a conference
34th Annual Growth Conference to be held in Boston on August 13-14.
11:04 EDTAXLAmerican Axle reaffirms FY14 revenue $3.7B, consensus $3.69B
Reaffirms FY15 revenue $4B, consensus $3.97B. Comment made at the J.P. Morgan Auto Conference.
08:44 EDTCVXShell to reduce 250 Aberdeen employees, FT says
Subscribe for More Information
06:42 EDTRBSRBS confirms possible Coutts sale, Reuters says
Subscribe for More Information
August 11, 2014
17:42 EDTCVXChevron awarded $104.46M government contract
Subscribe for More Information
15:23 EDTAXLJPMorgan to hold a conference
Subscribe for More Information
07:26 EDTRBSRBS Libor probe to extend as SFO weighs charges against traders, FT says
Subscribe for More Information
06:30 EDTRBSRBS plans to sell international arm of Coutts, Reuters reports
Subscribe for More Information
August 8, 2014
12:41 EDTBCORBlucora shares should be bought on weakness, says Barrington
Subscribe for More Information
10:16 EDTBCORHigh option volume stocks
High option volume stocks: TKMR JOE HMSY TDC XOMA XPO VGK DKS BCOR DRTX
10:15 EDTRBSRoyal Bank of Scotland winding down Global Restructuring Group, FT reports
Royal Bank of Scotland is set to wind down Global Restructuring Group, its restructuring unit which is under investigation over allegations it profited from "the financial distress of companies it was meant to help," the Financial Times reports, citing an internal memo. GRG head Derek Sach and Aubrey Adams, the head of property at the unit, will leave the bank in March 2015. Reference Link
10:00 EDTINVNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:24 EDTINVNInvenSense initiated with a Buy at Canaccord
Target $29.
06:18 EDTRBSRoyal Bank of Scotland's Hampton leads race to become new GSK chair, FT reports
Royal Bank of Scotland (RBS) Chairman Philip Hampton is the frontrunner to succeed Christopher Gent as chairman of GlaxoSmithKline (GSK), the Financial Times reports, citing sources. Gent will step down from his role at GSK next year. Hampton is not expected to step down from RBS until after May's general election, the sources say. Reference Link
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use